Related Experiment Video
Updated: Jun 22, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
Published on: September 28, 2012
Nuclear accumulation and activation of p53 in embryonic stem cells after DNA damage
Valeriya Solozobova1, Alexandra Rolletschek, Christine Blattner
1Institute of Toxicology and Genetics, Forschungszentrum Karlsruhe, PO-Box 3640, 76021 Karlsruhe, Germany. valeriya.solozobova@itg.fzk.de
Background:
P53 is a key tumor suppressor protein. In response to DNA damage, p53 accumulates to high levels in differentiated cells and activates target genes that initiate cell cycle arrest and apoptosis. Since stem cells provide the proliferative cell pool within organisms, an efficient DNA damage response is crucial.
Results:
In proliferating embryonic stem cells, p53 is localized predominantly in the cytoplasm. DNA damage-induced nuclear accumulation of p53 in embryonic stem cells activates transcription of the target genes mdm2, p21, puma and noxa. We observed bi-phasic kinetics for nuclear accumulation of p53 after ionizing radiation. During the first wave of nuclear accumulation, p53 levels were increased and the p53 target genes mdm2, p21 and puma were transcribed. Transcription of noxa correlated with the second wave of nuclear accumulation. Transcriptional activation of p53 target genes resulted in an increased amount of proteins with the exception of p21. While p21 transcripts were efficiently translated in 3T3 cells, we failed to see an increase in p21 protein levels after IR in embryonal stem cells.
Conclusion:
In embryonic stem cells where (anti-proliferative) p53 activity is not necessary, or even unfavorable, p53 is retained in the cytoplasm and prevented from activating its target genes. However, if its activity is beneficial or required, p53 is allowed to accumulate in the nucleus and activates its target genes, even in embryonic stem cells.
Insights
Embryonic stem cells retain p53 protein in the cytoplasm, preventing its tumor suppressor activity. Upon DNA damage, p53 translocates to the nucleus, activating essential target genes for cellular defense.
Area of Science:
- Cellular biology
- Molecular oncology
- Stem cell research
Background:
- p53 is a critical tumor suppressor protein.
- In differentiated cells, DNA damage triggers p53 accumulation and target gene activation for cell cycle arrest and apoptosis.
- A robust DNA damage response is vital in stem cells, which form the organism's proliferative pool.
Purpose of the Study:
- To investigate the DNA damage response of p53 in embryonic stem cells.
- To understand the regulation of p53 localization and activity in stem cells.
Main Methods:
- Exposure of embryonic stem cells to ionizing radiation.
- Analysis of p53 protein localization (cytoplasmic vs. nuclear).
- Quantification of p53 target gene mRNA and protein levels (mdm2, p21, puma, noxa).
Main Results:
- In proliferating embryonic stem cells, p53 is primarily cytoplasmic.
- Ionizing radiation induces bi-phasic nuclear accumulation of p53.
- Nuclear p53 activates transcription of mdm2, p21, puma, and noxa, but p21 protein levels do not increase.
- noxtranscription correlates with the second wave of nuclear p53 accumulation.
Conclusions:
- Embryonic stem cells maintain p53 in the cytoplasm to prevent anti-proliferative activity when not needed.
- p53 is permitted to accumulate in the nucleus and activate target genes when its function is beneficial or required, even in embryonic stem cells.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
Negative Regulator Molecules
Methods of Nuclear Reprogramming
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

